Android app Apple app link

Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs

By Yahoo! Finance   |   1 month ago
Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs

Pulse Biosciences CEO highlights advancements in commercializing their percutaneous electrode, clinical studies for atrial fibrillation, and US launch of soft tissue ablation product. The company plans to advance commercialization and initiate pivotal studies for cardiac devices in 2025.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

To become a member, please download and purchase membership through our app.